Surgalign appoints Board member Sheryl Conley as Chair of the Board of Directors

– USA, IL –  Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced the appointment of Sheryl Conley to the role of non-executive Chair of the Board of Directors, effective September 14, 2021, succeeding Stuart Simpson, who resigned from the Board of Directors, effective September 10, 2021, to focus on the responsibilities of his new position as CEO of THINK Surgical, Inc.

Sheryl Conley was appointed to the Board as a director on May 4, 2021, and has more than 35 years of expertise and broad-based executive leadership experience in the orthopedic medical device industry running full P&L business segments, global brand management, marketing, sales, product development, commercial and manufacturing operations.

“Sheryl has been an incredible addition to our Board and we are excited for her to now help guide the development of our Company as we position ourselves to be leaders in the evolution of surgery through the application of artificial intelligence, data analytics, and augmented reality,” said CEO, Terry Rich. “Sheryl’s extensive experience in the medical device industry, public company executive leadership, and experience in strategic transformations, along with her public board experience will further drive our mission to change surgery.”

About Sheryl Conley

Sheryl Conley served as President and CEO of OrthoWorx, Inc., a community-based initiative that works strategically and collaboratively with the orthopedic industry, from 2012-2017. Before that, she spent 25 years with Zimmer, Inc. in a series of escalating management roles where her last role was Group President and Chief Marketing Officer. Conley is a recognized leader in innovation and the creation of new markets in the orthopedic medical device space. She provided key leadership in the development and commercial release of more than 50 industry-leading brands. She currently serves as the President and Board Member of AcceLINX, Inc., a musculoskeletal health business accelerator (March 2017— present), and since 2019 has been a board director for Neuronetics, Inc. a medical technology company focused on developing products that improve the quality of life for patients suffering from psychiatric disorders.

“I have spent the entirety of my 35-year career helping to improve patient outcomes and change the way surgery is practiced and I am excited for this opportunity to serve as Chair of the Board,” said Sheryl Conley. “Surgalign is well-positioned to be a leader in the application of digital technology in the continuum of patient care and I look forward to partnering with the Company to reimagine surgery to support better patient outcomes.”

About Surgalign Holdings, Inc.

Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital surgery and is building out its digital surgery platform to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies surgeons will look to for what is truly possible for their patients. Surgalign is focused on bringing surgeons solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign, a member of AdvaMed, is headquartered in Deerfield, IL, with commercial, innovation, and design centers in San Diego, CA, Warsaw, Poland, and Wurmlingen, Germany.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team